Cargando…
RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
Although remarkable advances have been made in the treatment of rheumatoid arthritis (RA), novel therapeutic options with different mechanisms of action and fewer side effects have been expected. Recent studies have demonstrated that bone-resorbing osteoclasts are critically involved in the bone des...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480939/ https://www.ncbi.nlm.nih.gov/pubmed/31069051 http://dx.doi.org/10.12688/f1000research.17296.1 |